Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events.
J Am Acad Dermatol
; 88(6): 1271-1281, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-31870917
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Eruptions
/
Exanthema
Limits:
Humans
Language:
En
Journal:
J Am Acad Dermatol
Year:
2023
Type:
Article